Clinical Trials Browser

Phase 3 × INDUSTRY × satraplatin × Clear all

NCT00450970 2012-08-17

SPERA

Phase 3 Terminated

Prostatic Neoplasms

NCT00069745 2012-08-07

Satraplatin in Hormone Refractory Prostate Cancer Patients Previously Treated With One Cytotoxic Chemotherapy Regimen

Phase 3 Completed

Prostatic Neoplasms